PetVivo Holdings announced it has entered into a definitive distribution agreement with Covetrus North America. Covetrus will inventory, market and promote PetVivo’s veterinary medical device, Spryng with OsteoCushion technology, throughout the United States. Covetrus sales and marketing activities will commence on January 1, 2024. “We are incredibly pleased to add Covetrus to our current distribution network to distribute our signature product, Spryng with OsteoCushion technology. By adding Covetrus to our current distribution network, they will assist PetVivo as another strategic partner that will allow our Company significant exposure to and penetration in the US animal health market. We believe this new relationship will benefit the veterinary industry, the veterinarians who provide the medical care to their patients, the animals receiving Spryng as well as the owners benefiting from the enhanced medical outcomes of their animals,” stated John Lai, Chief Executive Officer for PetVivo.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on PETV:
- PetVivo Holdings, Inc. Achieves Distribution Milestone Surpassing 4500 Syringes of Spryng™ in 2023
- PetVivo achieves national distribution of Spryng to over 600 vet clinics
- PetVivo Holdings, Inc. Achieves National Distribution of Spryng™ to More than 600 Veterinary Clinics in 49 States
- PetVivo Holdings, Inc. to Exhibit at American Association of Equine Practitioners Conference in San Diego, California
- PetVivo Reports Second Quarter of Fiscal 2024 Financial Results
